Targeted citrullination enables p53 binding to non-canonical sites
Molecular Cell · 2025
DOI: 10.1016/j.molcel.2025.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025. Verfasst von Alexandra Indeglia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA; Graduate Group in Biochemistry and Molecular Biophy…. Hauptthemen laut MEDLINE: Protein-Arginine Deiminase Type 4, Citrullination, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA; Graduate Group in Biochemistry and Molecular Biophysics, the University of Pennsylvania Perelman School of Medicine, Phil…
- Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA; Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 1910…
- Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA; University of Bologna, Bologna, Italy.
- Program in Gene Regulation and Cell Signaling, The Wistar Institute, Philadelphia, PA 19104, USA; Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 1910…
- Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA; Cancer Biology Program, St Joseph's University, Philadelphia, PA, USA.
- Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104, USA; Proteomics and Metabolomics Shared Resource, The Wistar Institute, Philadelphia, PA 19104, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health National Cancer Institute
Zitieren
APA
Indeglia, A., Valdespino, A., Pantella, G., Offley, S., Hill, C., Foster, M., Casey, K., Tang, H. Y., Faustino, A. M., Gardini, A., & Murphy, M. E. (2025). Targeted citrullination enables p53 binding to non-canonical sites. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.09.004
Vancouver
Indeglia A, Valdespino A, Pantella G, Offley S, Hill C, Foster M, et al. Targeted citrullination enables p53 binding to non-canonical sites. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.09.004
BibTeX
@article{Indeglia2025,
author = {Indeglia, Alexandra and Valdespino, Andrea and Pantella, Giulia and Offley, Sarah and Hill, Connor and Foster, Maya and Casey, Kaitlyn and Tang, Hsin-Yao and Faustino, Anneliese M and Gardini, Alessandro and Murphy, Maureen E},
title = {Targeted citrullination enables p53 binding to non-canonical sites},
journal = {Molecular Cell},
year = {2025},
doi = {10.1016/j.molcel.2025.09.004}
}
EUVIMED